SENSEI, the first robotic gamma probe to be commercially available to European hospital systems, has received the CE Mark approval. The news was announced today. SENSEI has been designed for intra-operative detection of sentinel lymph nodes as well as cancer metastasis…
Occlutech, a Swiss-based privately-held company reported that the FDA has granted the Company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) patients with preserved (HFpEF) or reduced (HFrEF) ejection fraction. Heart failure…
In 2007, the Swedish Medical Products Agency, Läkemedelsverket, analysed the top 10 incidents in healthcare. It noticed that software was often the root cause – for example medical data being lost from a temporary database, medication being assigned to the wrong…
